Armitage James O, Bierman Philip J, Bociek R Gregory, Vose Julie M
Section of Oncology/Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha 68198, USA.
Oncology (Williston Park). 2006 Mar;20(3):231-9; discussion 242, 244, 249.
The past 20 years have brought significant advances in our ability to manage patients with non-Hodgkin's lymphoma. More precise classification systems, improvements in diagnosis and staging, and effective new treatments have improved outcomes and made cure a reasonable goal for many patients with these disorders. In this overview of the progress seen in the field over the past 2 decades, we describe a variety of advances for specific lymphomas, including diagnostic methods such as gene array studies and immunophenotyping and new treatment approaches.
在过去20年里，我们管理非霍奇金淋巴瘤患者的能力取得了重大进展。更精确的分类系统、诊断和分期的改善以及有效的新疗法提高了治疗效果，使治愈成为许多患有这些疾病的患者的合理目标。在这篇对过去20年该领域进展的综述中，我们描述了特定淋巴瘤的各种进展，包括基因芯片研究和免疫表型分析等诊断方法以及新的治疗方法。
